Medtronic MiniMed 640G Insulin Pump Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medtronic MiniMed, Inc. is recalling 116,645 units of MiniMed 640G Insulin Pumps due to potential over- and under-delivery of insulin from gravitational forces, which could lead to severe health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Recall Article
What Happened
The recall is due to unintended over- and under-delivery of insulin in Medtronic MiniMed infusion pumps when the pump is elevated or lowered relative to the infusion site, caused by changes in gravitational force impacting pressures.
Which Products Are Affected
The affected products are MiniMed 640G Insulin Pumps with model numbers MMT-1711, MMT-1712, MMT-1751, and MMT-1752. A total of 116,645 units are involved, with distribution including US Nationwide in states such as OR, CA, AZ, NY, TX, FL, OH, MO, TN, NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS, IA, MI, NH, OK, SD, MT, WI, WV, MA, LA, MN, RI, AR, ME, AL, IN, UT, KY, CO, ND, MD, CT, NM, KS, ID, NV, DE, NE, VT, AK, HI, WY, PR, VI, and countries worldwide. The recall number is Z-1743-2026, and code information includes various UDI-DI/GTIN numbers such as 643169999763, 763000002763, and others listed in the source.
What You Should Do
Consumers should follow the initial firm notification, which was sent via letter, and contact the recalling firm, Medtronic MiniMed, Inc., at their address: 18000 Devonshire St, Northridge, CA 91325-1219, for information on returns or refunds related to this voluntary recall.
Why This Matters
This recall affects a large number of insulin pumps worldwide, potentially leading to serious health risks such as severe hypoglycemia, seizures, coma, or death from over-delivery, and severe hyperglycemia or diabetic ketoacidosis from under-delivery.
Source
FDA Recall Notice: Event ID 98186
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,531 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.